ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996